Report Feature
The future of the companion diagnostic market looks promising with opportunities in the pharmaceutical and biopharmaceutical companies, and reference lab. The global companion diagnostic market is ex
pected to grow with a CAGR of 20% from 2019 to 2024. The major growth drivers for this market are improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence , and increasing collaborations and partnerships for companion diagnostics test development.A report of more than 150 pages developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of companion diagnostic market report download the report brochure
The study includes the companion diagnostic market size and forecast for the global companion diagnostic market through 2024, segmented by product and service, technology, indication, end use, and region as follows:
By Product and Service [$M shipment analysis for 2013 – 2024]:
- Assays & Reagents
- Software & Services
By Technology [$M shipment analysis for 2013 – 2024]:
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Next-generation Sequencing
- Other Technologies
By Indication [$M shipment analysis for 2013 – 2024]:
- Oncology
- Neurology
- Other Indications
By End Use [$M shipment analysis for 2013 – 2024]:
- Pharmaceutical and Biopharmaceutical Companies
- Reference Lab
- Other End Users
By Region [$M shipment analysis for 2013 – 2024]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
-
Asia Pacific
- China
- India
- Japan
-
Rest of the World
- Brazil
Some of the companion diagnostics companies profiled in this report include F. Hoffmann-La Roche, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Biomérieux, Danaher, Illumina, Myriad Genetics, Arup Laboratories, Sysmex, Hologic, Novartis, Almac Group, and Abnova.
Some of the features of this report:
- Market size estimates: Global companion diagnostic market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis: Global market size by various applications such as by product and service, technology, indication, end use, and region.
- Regional analysis: Global companion diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities: Analysis on growth opportunities in different applications and regions for companion diagnostics in the global companion diagnostic market.
- Strategic analysis: This includes M&A, new product development, and competitive landscape for, companion diagnostics in the global companion diagnostic market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Table of Contents
1. Executive Summary 2. Market Background and Classifications 2.1: Introduction, Background, and Classifications 2.2: Supply Chain 2.3: Industry Drivers and Challenges
5. Competitor Analysis 5.1: Product Portfolio Analysis 5.2: Market Share Analysis 5.3: Operational Integration 5.4: Geographical Reach 5.5: Porter’s Five Forces Analysis
7. Company Profiles of Leading Players 7.1: F. Hoffmann-La Roche 7.2: Agilent Technologies 7.3: Qiagen 7.4: Thermo Fisher Scientific 7.5: Abbott Laboratories 7.6: Biomérieux 7.7: Danaher 7.8: Illumina 7.9: Myriad Genetics 7.10: Arup Laboratories
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising potential, high-growth opportunities for the global companion diagnostic market by product and service (assays and reagents and software and services), technology (polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH) , next-generation sequencing, and other technologies), indication (oncology, neurology, others, and other indications), end use (pharmaceutical and biopharmaceutical companies, reference lab, and other end user), and region (North America, Europe, Asia-Pacific, and ROW)?
- • Which segments will grow at a faster pace and why?
- • Which regions will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the drivers and challenges of the companion diagnostic market?
- • What are the business risks and threats to the companion diagnostic market?
- • What are emerging trends in this companion diagnostic market and the reasons behind them?
- • What are some changing demands of customers in the companion diagnostic market?
- • What are the new developments in the companion diagnostic market? Which companies are leading these developments?
- • Who are the major players in this companion diagnostic market? What strategic initiatives are being implemented by key players for business growth?
- • What are some of the competitive products and processes in this companion diagnostics area and how big of a threat do they pose for loss of market share via material or product substitution?
- • What M & A activities have taken place in the last 5 years in companion diagnostic market?
